In our study, the increase in liver GSDMD activation preceded the increase in circulating HMGB1 levels during endotoxemia, and hepatocyte-specific Gsdmd deficiency decreased the plasma HMGB1 concentration and improved the survival of mice from 10% to 100%. The gene discussed is GSDMD; the disease is serum lipopolysaccharide activity.